Ultime notizie per Bavarian Nordic (OTC:BVNKF) Azioni

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

BAVARIAN NORDIC A S by Bavarian Nordic A/S

Bavarian Nordic AS

Bavarian Nordic

Screenshot 2025-03-19 at 8.55.22 PM

Biotech

BVNKF

TNXP

As Mpox Cases Spread Around The World, Tonix Pharmaceuticals&#39; Single-Dose Vaccine TNX-801 Has Potential To Slow The Spread

Screenshot 2024-09-18 at 12.30.33 AM

General

New Hope For Mpox? How TNX-801 Could Meet The WHO&#39;s Vaccine Targets For A Safer, Single-Dose Solution

Comments

Bavarian Nordic

Notizie

Ultime notizie per Bavarian Nordic (OTC:BVNKF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO